Cancer Immunotherapy Drugs Driving End-of-Life Cost Increases

Immunotherapy drugs accounted for 84% of the overall increase in Medicare Part B spending for end-of-life outpatient cancer care.
Medscape Medical News

source https://www.medscape.com/viewarticle/989010?src=rss